Could an earthworm enzyme ease the burden of long covid and chronic fatigue?
NCT ID NCT06511050
Summary
This early-stage study is testing whether a supplement called lumbrokinase can improve overall health and reduce symptoms for people with three debilitating long-term conditions: Long Covid, chronic Lyme disease, and ME/CFS (chronic fatigue syndrome). The trial will enroll 120 adults to see if taking lumbrokinase is safe and feasible, and if it helps with energy, pain, brain fog, and quality of life. It's a first step to see if this approach is worth larger future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE)
RECRUITINGNew York, New York, 10029, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.